FDA approves breakthrough pancreatic cancer drug
The FDA has approved Rasonque, a new targeted pancreatic cancer treatment from Revolution Medicines.
Original Source
Read the full article at Cleveland →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.